Vírus da Covid-19 — Aumenta a Incidência de Urticária?
To clearly understand the clinical aspects involved in Urticaria This is an essential step for those seeking diagnostic certainty, lasting symptom relief, and prevention of complications. In the daily practice of Allergology and Clinical Immunology, questions related to... "Vírus da Covid-19 — Aumenta a Incidência de Urticária?" Allergy-free conditions are common among patients and their families. The goal of this page in the Brazil Allergy-Free Encyclopedia is to present a complete, accessible, and evidence-based medical analysis, detailing causes, immunological mechanisms, and safe practices.
✔ Medical content reviewed and validated by the founding clinical staff of the Brazil Without Allergies Project
Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.
Vírus da Covid-19 e o Aumento na Incidência de Urticária
A urticária é uma condição dermatológica caracterizada pelo surgimento de lesões avermelhadas, elevadas e frequentemente acompanhadas de intensa coceira. Na prática médica e na literatura especializada, ela é classicamente dividida em duas formas principais: a urticária aguda, que se manifesta por um período inferior a seis semanas, e a urticária crônica, cujos sintomas persistem por mais de seis semanas.
Enquanto as formas crônicas frequentemente envolvem mecanismos imunológicos complexos — podendo estar associadas a outras condições autoimunes —, os quadros agudos são frequentemente deflagrados por fatores externos bem definidos. Dentre as causas mais comuns da urticária aguda, destacam-se as infecções virais, as intoxicações e as reações adversas a medicamentos.
A Relação entre Infecções Virais e o Mastócito
O principal ator celular envolvido no surgimento da urticária é o mastócito. Na superfície dessas células, existem estruturas proteicas especializadas conhecidas como receptores do tipo Toll (ou receptores Toll-like). Esses receptores têm a capacidade de reconhecer componentes de diversos agentes infecciosos, incluindo vírus respiratórios e sistêmicos, como os vírus da gripe, o Epstein-Barr (causador da mononucleose) e o citomegalovírus.
Quando o agente viral interage com esses receptores na membrana do mastócito, pode ocorrer a ativação e a desgranulação celular. Esse processo resulta na liberação imediata de mediadores inflamatórios, principalmente a histamina, culminando no aparecimento das placas urticariformes na pele.
O Impacto da Pandemia de Covid-19
Esse mesmo mecanismo fisiopatológico aplica-se ao vírus SARS-CoV-2, responsável pela Covid-19. Com o avanço das observações clínicas e epidemiológicas durante e após a pandemia, documentou-se um aumento real de aproximadamente 20% nos casos de urticária aguda associados à infecção pelo coronavírus. Dessa forma, muitos pacientes que contraíram a Covid-19 passaram a apresentar episódios de urticária aguda como manifestação cutânea pós-infecção.
Nota: Este conteúdo possui caráter exclusivamente educativo e informativo, não substituindo em hipótese alguma a consulta, o diagnóstico e a avaliação individualizada com um médico especialista.
Developments in Evidence-Based Medicine: Pathophysiology and Staged Management of Urticaria and Angioedema
In accordance with the international guideline EAACI/GA²LEN/EuroGuiDerm/APAAACI for the management of urticaria and angioedemaDegranulation of cutaneous mast cells with the release of histamine, platelet-activating factor (PAF), and cytokines promotes vasodilation, dermal plasma extravasation (fleeting pruritic papules/hives or submucosal/subcutaneous angioedema), and cell recruitment. To distinguish histaminergic angioedema from bradykinin-mediated angioedema (associated with C1-esterase inhibitor deficiency/dysfunction — C1-INH — or the use of ACE inhibitors), the presence of hives, the response to antihistamines, and the C4 and C1-INH levels are evaluated. First-line pharmacological treatment of chronic urticaria is based on non-sedating second-generation H1 antihistamines in standard doses, which can be increased up to four times the usual dose under medical prescription before the indication of anti-IgE immunobiological therapy.
💎 Diamond Plan — Peaceful skin, free from constant itching and sleepless flare-ups. Speak with an Allergy and Immunology specialist via teleconsultation, from anywhere in Brazil. Schedule a teleconsultation →
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Pathophysiology of Urticaria and Angioedema: Safe Diagnosis and Management
Mast Cell Activation, Histamine, and the Bradykinin Pathway
Urticaria is characterized by the sudden appearance of hives (intensely itchy, erythematous and edematous papules that are fleeting and disappear in less than 24 hours in the same spot without leaving a scar), and may be accompanied by angioedema in the deeper layers of the dermis and submucosa. In acute cases (lasting less than six weeks), viral infections, foods, and medications are among the classic triggers; while in chronic spontaneous urticaria or induced urticaria (dermographic, cholinergic due to sweat/heat, cold, or delayed pressure), autoimmune mechanisms or mast cell hyperreactivity play a central role.
Therapeutic Escalation without Overuse of Corticosteroids
As diretrizes internacionais preconizam os anti-histamínicos H1 de segunda geração (não sedativos) em doses otimizadas sob supervisão médica como primeira linha, reservando anticorpos monoclonais anti-IgE (como o omalizumabe) para casos crônicos refratários e evitando ciclos repetidos de corticoides sistêmicos que causam efeito rebote. A investigação com allergy test e avaliação especializada de pele permite excluir gatilhos ocultos e alinhar, quando há atopia coexistente, estratégias como a allergy vaccine.
Vaccine Mechanisms, Excipients, and Assessment of Immune Competence
In assessing the competence of the immune system—whether in recurrent infections, laboratory alterations in immunoglobulins (IgG, IgA, IgM, IgE), or in people living with HIV under monitoring of CD4 T lymphocyte counts—a careful distinction is made between the use of inactivated/subunit vaccines (widely safe even in immunocompromised individuals) and live attenuated vaccines, whose indication depends on the degree of preservation of cellular immunity. Furthermore, patients undergoing allergy immunotherapy can maintain their vaccination schedule, respecting only small operational intervals as directed by the medical team.
Eixo Inflamatório Th1/Th17, Gatilhos Ambientais e Barreira Epidérmica
Unlike purely IgE-mediated dermatoses, psoriasis and related autoimmune conditions involve the activation of plasmacytoid dendritic cells, interferon-gamma production, and sustained stimulation of the interleukin-23/interleukin-17 (IL-23/IL-17) and TNF-alpha axis. This signaling accelerates the epidermal keratinocyte renewal cycle several times over, resulting in well-defined erythematous-desquamative plaques and, in some patients, associated joint inflammation. Infections, mechanical or chemical trauma to the skin (Koebner phenomenon), dry winter weather, and emotional stress act as important amplifiers of the inflammatory response.
Immediate Reactions, Delayed Drug Reactions, and Risks of Self-Medication
Another critical pharmacovigilance point concerns the indiscriminate use of long-acting oral or injectable systemic corticosteroids (such as intramuscular betamethasone combinations). Although they provide apparent rapid relief, repeated applications suppress the hypothalamic-pituitary-adrenal axis, raise blood pressure and blood glucose, demineralize bone mass, weaken immunity against infections, and can cause local neuropathic pain when improperly applied to the gluteal region.
Diamond Plan: Specialized Allergy Treatment Wherever You Are
We know that, for many families, allergy treatment faces two concrete obstacles: high cost of allergy vaccines and the distance to a specialized centerThe Diamond Plan It was created precisely to remove these barriers, combining teleconsultation with specialists and easy access to immunotherapy throughout the country. For peaceful skin, free from constant itching and sleepless nights due to flare-ups.
Why do patients across Brazil choose the Diamond Plan?
- Teleconsultation with a specialist In Allergy and Immunology, without queues and without long commutes — ideal for those who live far from large cities.
- easy access to Immunotherapy (including allergy vaccines and immunostimulants) — indicated for the treatment of allergic rhinitis, asthma, bronchitis, atopic dermatitis, insect/mosquito bite allergy (prurigo strophulus), recurrent candidiasis, and for increasing immunity in selected patients — capable of modifying the natural course of allergic disease, always through consultation and individualized prescription.
- A more accessible route For those facing the high cost of allergy vaccines, this plan offers support for continuity of treatment.
- Continuous monitoring based on clinical evolution, with adjustments to treatment throughout the entire therapeutic cycle.
- National coverage, backed by a consolidated physical network and a founding clinical team with over three decades of experience.
More than 30 years caring for people with allergies.
Founded and run by Dr. Marcello Bossois (CRM-RJ 52.73214-1) and by Dr. Patrícia Schlinkert (CRM/RJ 5274541-3)The Brazil Without Allergies Project adds... more than 30 years of history and more than 450,000 free services, with physical presence at Rio de Janeiro, São Paulo and Paraná, one mobile clinic bus that brings testing and consultations to communities with limited access to specialized care and a platform of telemedicine which connects patients from all states to the same standard of care.
START TODAY
Your expert consultation is just a click away.
I want to join the Diamond Plan.Schedule a teleconsultation
Official telemedicine environment: brasilsemalergia.online
Do you prefer to be served in person?
Our clinical units They conduct consultations, allergy tests, and immunotherapy follow-up with doctors in person:
- Rio de Janeiro: Realengo (West Zone), North Zone, Duke of Caxias, Xerém, New Iguaçu, Itaguaí, Niterói, Iguaba Grande and Saint Peter of the Village (Lakes Region).
- São Paulo: Campo Limpo (South Zone).
- Paraná: Curitiba.
Schedule your in-person appointment. Or check the mobile bus schedule through the customer service center on WhatsApp. (21) 99954-5632.
The indication for immunotherapy, and for any treatment, depends on an individual medical evaluation. This content is for informational purposes only and does not replace consultation with a specialist.
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Conclusion and Summary of Guidelines
In summary, the appropriate approach to Urticaria This requires a clear understanding of the immunological mechanisms involved, precise etiological diagnosis, and individualized medical follow-up. Avoid self-medication and investigate the root cause of symptoms—relying on specialized resources and reliable guidance such as... rhinitis treatment When clinically relevant, it is the safest way to manage crises, prevent complications, and ensure sustainable quality of life.
Scientific references and authoritative sources
The guidelines on this page follow the guidelines and literature of leading international Allergy and Immunology institutions. For further information:




